These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 33763860)

  • 1. The Contributions of Clinical Pharmacology to HIV Cure Research.
    Fletcher CV; Dyavar SR; Acharya A; Byrareddy SN
    Clin Pharmacol Ther; 2021 Aug; 110(2):334-345. PubMed ID: 33763860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of CD8β Depletion and Interleukin-15 Superagonist N-803 Induces Virus Reactivation in Simian-Human Immunodeficiency Virus-Infected, Long-Term ART-Treated Rhesus Macaques.
    McBrien JB; Wong AKH; White E; Carnathan DG; Lee JH; Safrit JT; Vanderford TH; Paiardini M; Chahroudi A; Silvestri G
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection.
    Tsai P; Wu G; Baker CE; Thayer WO; Spagnuolo RA; Sanchez R; Barrett S; Howell B; Margolis D; Hazuda DJ; Archin NM; Garcia JV
    Retrovirology; 2016 May; 13(1):36. PubMed ID: 27206407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent developments in the effort to cure HIV infection: going beyond N = 1.
    Siliciano JD; Siliciano RF
    J Clin Invest; 2016 Feb; 126(2):409-14. PubMed ID: 26829622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Class 1-Selective Histone Deacetylase (HDAC) Inhibitors Enhance HIV Latency Reversal while Preserving the Activity of HDAC Isoforms Necessary for Maximal HIV Gene Expression.
    Zaikos TD; Painter MM; Sebastian Kettinger NT; Terry VH; Collins KL
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29298886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations for measuring HIV reservoir size in cure-directed clinical trials.
    Abdel-Mohsen M; Richman D; Siliciano RF; Nussenzweig MC; Howell BJ; Martinez-Picado J; Chomont N; Bar KJ; Yu XG; Lichterfeld M; Alcami J; Hazuda D; Bushman F; Siliciano JD; Betts MR; Spivak AM; Planelles V; Hahn BH; Smith DM; Ho YC; Buzon MJ; Gaebler C; Paiardini M; Li Q; Estes JD; Hope TJ; Kostman J; Mounzer K; Caskey M; Fox L; Frank I; Riley JL; Tebas P; Montaner LJ;
    Nat Med; 2020 Sep; 26(9):1339-1350. PubMed ID: 32895573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of HIV Cure: Site of Action.
    Devanathan AS; Cottrell ML
    Clin Pharmacol Ther; 2021 Apr; 109(4):841-855. PubMed ID: 33540481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4
    Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S
    J Virol; 2018 May; 92(9):. PubMed ID: 29444937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VIP-SPOT: an Innovative Assay To Quantify the Productive HIV-1 Reservoir in the Monitoring of Cure Strategies.
    Puertas MC; Bayón-Gil Á; Garcia-Guerrero MC; Salgado M; Urrea V; Morón-López S; Peña R; Jiménez-Moyano E; Clotet B; Prado JG; Martinez-Picado J
    mBio; 2021 Jun; 12(3):e0056021. PubMed ID: 34154408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of histone deacetylase inhibitors on HIV production in latently infected, resting CD4(+) T cells from infected individuals receiving effective antiretroviral therapy.
    Blazkova J; Chun TW; Belay BW; Murray D; Justement JS; Funk EK; Nelson A; Hallahan CW; Moir S; Wender PA; Fauci AS
    J Infect Dis; 2012 Sep; 206(5):765-9. PubMed ID: 22732922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat.
    Olesen R; Vigano S; Rasmussen TA; Søgaard OS; Ouyang Z; Buzon M; Bashirova A; Carrington M; Palmer S; Brinkmann CR; Yu XG; Østergaard L; Tolstrup M; Lichterfeld M
    J Virol; 2015 Oct; 89(20):10176-89. PubMed ID: 26223643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A New Quinoline BRD4 Inhibitor Targets a Distinct Latent HIV-1 Reservoir for Reactivation from Other "Shock" Drugs.
    Abner E; Stoszko M; Zeng L; Chen HC; Izquierdo-Bouldstridge A; Konuma T; Zorita E; Fanunza E; Zhang Q; Mahmoudi T; Zhou MM; Filion GJ; Jordan A
    J Virol; 2018 May; 92(10):. PubMed ID: 29343578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: a Functional Latent Reservoir.
    Avalos CR; Abreu CM; Queen SE; Li M; Price S; Shirk EN; Engle EL; Forsyth E; Bullock BT; Mac Gabhann F; Wietgrefe SW; Haase AT; Zink MC; Mankowski JL; Clements JE; Gama L
    mBio; 2017 Aug; 8(4):. PubMed ID: 28811349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinations of Histone Deacetylase Inhibitors with Distinct Latency Reversing Agents Variably Affect HIV Reactivation and Susceptibility to NK Cell-Mediated Killing of T Cells That Exit Viral Latency.
    Covino DA; Desimio MG; Doria M
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged viral suppression with anti-HIV-1 antibody therapy.
    Gaebler C; Nogueira L; Stoffel E; Oliveira TY; Breton G; Millard KG; Turroja M; Butler A; Ramos V; Seaman MS; Reeves JD; Petroupoulos CJ; Shimeliovich I; Gazumyan A; Jiang CS; Jilg N; Scheid JF; Gandhi R; Walker BD; Sneller MC; Fauci A; Chun TW; Caskey M; Nussenzweig MC
    Nature; 2022 Jun; 606(7913):368-374. PubMed ID: 35418681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Latency Reversal Agents for HIV-1 Cure.
    Spivak AM; Planelles V
    Annu Rev Med; 2018 Jan; 69():421-436. PubMed ID: 29099677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic Patients.
    Spivak AM; Bosque A; Balch AH; Smyth D; Martins L; Planelles V
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5984-91. PubMed ID: 26169416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Immunodeficiency Virus 1 (HIV-1): Viral Latency, the Reservoir, and the Cure.
    Ventura JD
    Yale J Biol Med; 2020 Sep; 93(4):549-560. PubMed ID: 33005119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonhuman Primate Testing of the Impact of Different Regulatory T Cell Depletion Strategies on Reactivation and Clearance of Latent Simian Immunodeficiency Virus.
    Sivanandham R; Kleinman AJ; Sette P; Brocca-Cofano E; Kilapandal Venkatraman SM; Policicchio BB; He T; Xu C; Swarthout J; Wang Z; Pandrea I; Apetrei C
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scientists investigate routing latent HIV from its reservoirs to achieve a cure.
    Friedrich MJ
    JAMA; 2012 Jul; 308(4):325-7. PubMed ID: 22820767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.